Insider · CIK 0001188940

COLA MICHAEL F

Reports to the SEC for 7 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001188940

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+24.1K sh	—	—	63,920
2025-07-31	Sage Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.5K sh	—	—	0
2025-06-11	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+21.5K sh	—	—	21,500
2025-06-03	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+10.5K sh	—	—	39,798
2025-06-03	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2024-06-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-05-23	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	−17.5K sh	—	—	17,500
2024-05-23	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+10.5K sh	—	—	29,298
2023-06-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-05-25	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-25	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+9,000 sh	—	—	18,798
2022-06-16	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,947 sh	—	—	9,947
2022-05-25	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-10-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+78.1K sh	—	—	78,116
2021-07-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+51.7K sh	—	—	51,740
2021-06-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-05-21	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-04-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70.9K sh	—	—	70,881
2021-01-26	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+850K sh	—	—	850,000
2021-01-04	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+64.8K sh	—	—	64,798
2020-10-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+76.7K sh	—	—	76,674
2020-07-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+64.7K sh	—	—	64,683
2020-06-18	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+84.3K sh	—	—	84,322
2020-06-09	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100K sh	$2.50	+$250K	175,746
2020-06-09	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-09	Aevi Genomic Medicine, LLCP Purchase	Director, Chief Executive Officer	PPurchase	+100K sh	$2.50	+$250K	175,746
2020-05-21	PHATPhathom Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2020-02-03	AVTXAvalo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+75.7K sh	—	—	75,746
2020-02-03	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.2M sh	—	—	1,200,000
2020-02-03	Aevi Genomic Medicine, LLCWarrant (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−21.2K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.5M sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−661K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−450K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−250K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−250K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−292K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2.27M sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−17.3K sh	—	—	0
2019-12-05	Aevi Genomic Medicine, LLCP Purchase	Director, Chief Executive Officer	PPurchase	+2.05M sh	$0.13	+$275K	2,267,859
2019-10-29	PHATPhathom Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+9,798 sh	$19.00	+$186K	9,798
2019-06-13	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-13	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	15,000
2019-06-05	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-14	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)A Award	Director, Chief Executive Officer	AAward	+661K sh	—	—	661,000
2018-06-13	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-13	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	10,000
2018-06-06	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-14	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)A Award	Director, Chief Executive Officer	AAward	+450K sh	—	—	450,000
2017-10-17	Aevi Genomic Medicine, LLCWarrant (right to buy)P Purchase	Director, Chief Executive Officer	PPurchase	+21.2K sh	—	—	21,181

Recent filings

Accepted (ET)
May 214
COLA MICHAEL F0001193125-26-234566
SEC(opens sec.gov)
Jul 314
COLA MICHAEL F0000950170-25-100680
SEC(opens sec.gov)
Jun 134
COLA MICHAEL F0001562180-25-004788
SEC(opens sec.gov)
Jun 54
COLA MICHAEL F0000950170-25-082456
SEC(opens sec.gov)
Jun 114
COLA MICHAEL F0001562180-24-004949
SEC(opens sec.gov)
May 244
COLA MICHAEL F0000950170-24-064830
SEC(opens sec.gov)
Jun 164
COLA MICHAEL F0001562180-23-005258
SEC(opens sec.gov)
May 304
COLA MICHAEL F0001209191-23-033004
SEC(opens sec.gov)
Jun 174
COLA MICHAEL F0001562180-22-005206
SEC(opens sec.gov)
May 274
COLA MICHAEL F0001209191-22-032574
SEC(opens sec.gov)
Feb 184
COLA MICHAEL F0001209191-22-011484
SEC(opens sec.gov)
Oct 44
COLA MICHAEL F0001878894-21-000003
SEC(opens sec.gov)
Jul 24
COLA MICHAEL F0001192482-21-000611
SEC(opens sec.gov)
Jun 114
COLA MICHAEL F0001562180-21-004208
SEC(opens sec.gov)
May 244
COLA MICHAEL F0001209191-21-035470
SEC(opens sec.gov)
Apr 54
COLA MICHAEL F0001192482-21-000303
SEC(opens sec.gov)
Jan 284
COLA MICHAEL F0001192482-21-000119
SEC(opens sec.gov)

Companies

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932